Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$120,649,899
-$12,017,379 QoQ
Shares Held
954,962
+0.3% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#127
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $3,560,811,525 across 15 Drug Manufacturers - General names. GILD ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
876,181 | $1,050,917,864 | |
| 2 | JNJ |
Johnson & Johnson
|
1,962,221 | $498,345,267 | |
| 3 | ABBV |
AbbVie Inc.
|
1,561,703 | $392,986,942 | |
| 4 | AZN |
Astrazeneca PLC
|
1,978,508 | $375,164,686 | |
| 5 | NVS |
Novartis AG
|
2,386,527 | $374,016,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,857,628 | $367,205,197 | |
| 7 | AMGN |
Amgen Inc
|
381,869 | $138,282,402 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
954,962 | $120,649,899 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,649,899 | 954,962 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $132,667,278 | 951,907 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $95,275,574 | 776,239 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $71,749,956 | 646,396 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $69,700,753 | 628,671 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $56,045,505 | 500,183 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $30,919,656 | 334,737 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $14,199,393 | 169,363 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $9,842,173 | 143,451 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $13,143,906 | 179,439 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $22,652,016 | 279,620 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $18,203,600 | 242,909 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $18,881,456 | 244,991 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $21,124,244 | 254,601 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $16,750,365 | 195,112 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $9,832,584 | 159,387 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,433,727 | 136,446 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,062,931 | 68,342 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $12,055,510 | 166,031 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $9,898,233 | 141,707 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,507,293 | 138,067 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $7,135,733 | 110,409 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $5,002,145 | 85,859 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,432,742 | 101,800 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $12,983,163 | 168,744 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $14,012,416 | 187,432 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||